[Elsevier] Response to correspondence on ‘Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind |
|
This post will be closed automatically in 2026-09-17 15:06
Best Answer
Yesterday 15:08
|
| |
15
Banking in the storm: How natural disaster influence non-performing loans and the path to sustainability in Vietnam
10
Electroacupuncture for weight loss by regulating microglial polarization in the arcuate nucleus of the hypothalamus
10
Integrative approach of machine learning and symbolic regression for stability prediction of multicomponent perovskite oxides and high-throughput screening
10
Understanding the role of trade agreements in Indonesia’s FDI
10
Xihuang pill suppresses triple-negative breast cancer via regulating AXL/TGF-β1/RhoA/ROCK and ERK pathway
